Partial improvement of solar urticaria after omalizumab.
Waibel
Kirk H
KH
Reese
Drew A
DA
Hamilton
Robert G
RG
Devillez
Richard L
RL
D000293:Adolescent; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D008297:Male; D000069444:Omalizumab; D010787:Photosensitivity Disorders / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D013472:Sunlight / Q000009:adverse effects*; D014581:Urticaria / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E